Inmune Bio Inc (INMB)

11:29 AM

INmune Bio: Imminent Phase 2 Alzheimer's Readout Of Unique Asset Presents Interesting Speculative Opportunity - Seeking Alpha

11:29 AM

Jun 11, 2025

INmune Bio, Inc. (NASDAQ:INMB) Shares Bought by Two Sigma Investments LP - Defense World

Jun 11, 2025

Jun 10, 2025

(INMB) On The My Stocks Page - news.stocktradersdaily.com

Jun 10, 2025

Jun 10, 2025

INmune Bio Collaborates on TBI and Alzheimer’s Study - TipRanks

Jun 10, 2025

Jun 10, 2025

INmune Bio, Inc. Collaborates on Study Showing XPro™ Treatment Reduces Alzheimer’s-like Pathology After Traumatic Brain Injury in Mice - Nasdaq

Jun 10, 2025

Jun 10, 2025

XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer's Disease: Supported by Department of Defense - The Manila Times

Jun 10, 2025

Jun 10, 2025

Xpro(TM) Reduces Amyloid And Enhances Behavior Post - marketscreener.com

Jun 10, 2025

Jun 10, 2025

Breakthrough: New Drug Reduces Alzheimer's Risk After Brain Injury, DoD-Backed Study Shows - Stock Titan

Jun 10, 2025

Jun 09, 2025

Two Sigma Advisers LP Takes Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Jun 09, 2025

Jun 04, 2025

Lucid Capital Markets initiates Buy rating for INmune Bio stock - Investing.com India

Jun 04, 2025

Jun 04, 2025

Lucid Capital Markets initiates Buy rating for INmune Bio stock By Investing.com - Investing.com Nigeria

Jun 04, 2025

Jun 04, 2025

INMB Stock Set for Growth with Positive Analyst Coverage | INMB Stock News - GuruFocus

Jun 04, 2025

Jun 04, 2025

Millennium Management LLC Boosts Stake in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Jun 04, 2025

Jun 03, 2025

Are You MINDFuL Of INmune Bio's Upcoming Alzheimer's Trial Readout? - RTTNews

Jun 03, 2025

Jun 01, 2025

Northern Trust Corp Acquires 9,154 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Jun 01, 2025

Jun 01, 2025

BNP Paribas Financial Markets Has $119,000 Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Jun 01, 2025

May 29, 2025

When (INMB) Moves Investors should Listen - news.stocktradersdaily.com

May 29, 2025

May 18, 2025

Where are the Opportunities in (INMB) - news.stocktradersdaily.com

May 18, 2025

May 18, 2025

Dimensional Fund Advisors LP Acquires 10,491 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 18, 2025

May 15, 2025

INmune Bio: XPro Trial Readout In Alzheimer’s Disease Offers Big Opportunity (NASDAQ:INMB) - Seeking Alpha

May 15, 2025

May 15, 2025

Wells Fargo & Company MN Buys 2,155 Shares of INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 15, 2025

May 14, 2025

INmune Bio to Attend RBC Healthcare Conference - TipRanks

May 14, 2025

May 14, 2025

INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference - The Manila Times

May 14, 2025

May 14, 2025

INmune Bio Sets Stage for Key Biotech Insights at RBC Healthcare Conference Next Week - Stock Titan

May 14, 2025

May 14, 2025

Raymond James raises INmune Bio stock target to $23 - MSN

May 14, 2025

May 14, 2025

Barclays PLC Increases Stake in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 14, 2025

May 13, 2025

Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - MSN

May 13, 2025

May 13, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 12, 2025

INmune Bio’s Earnings Call: Promise and Challenges - TipRanks

May 12, 2025

May 10, 2025

Mariner LLC Acquires New Holdings in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 10, 2025

May 09, 2025

Earnings call transcript: INmune Bio Q1 2025 shows narrowed losses, stock rises - Investing.com

May 09, 2025

May 09, 2025

INmune Bio Reports Q1 2025 Results and Updates - TipRanks

May 09, 2025

May 08, 2025

INMUNE BIO Earnings Results: $INMB Reports Quarterly Earnings - Nasdaq

May 08, 2025

May 08, 2025

INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - The Manila Times

May 08, 2025

May 08, 2025

(INMB) Trading Signals - news.stocktradersdaily.com

May 08, 2025

May 08, 2025

INmune Bio appoints new accounting firm By Investing.com - Investing.com Nigeria

May 08, 2025

May 07, 2025

INmune Bio appoints new accounting firm - Investing.com

May 07, 2025

May 07, 2025

INmune Bio Inc (INMB) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

May 07, 2025

May 07, 2025

JPMorgan Chase & Co. Has $53,000 Stock Holdings in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 07, 2025

May 05, 2025

INmune Bio Inc expected to post a loss of 47 cents a shareEarnings Preview - TradingView

May 05, 2025

May 05, 2025

INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th - The Manila Times

May 05, 2025

May 05, 2025

INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on ... - Eagle-Tribune

May 05, 2025

May 02, 2025

Renaissance Technologies LLC Increases Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 02, 2025

May 02, 2025

LPL Financial LLC Boosts Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

May 02, 2025

May 02, 2025

INmune Bio, Inc. (NASDAQ:INMB) Receives $22.80 Average PT from Analysts - Defense World

May 02, 2025

May 01, 2025

INmune Bio (INMB) Expected to Announce Quarterly Earnings on Thursday - Defense World

May 01, 2025

Apr 30, 2025

Geode Capital Management LLC Has $1.70 Million Stock Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Apr 30, 2025

Apr 23, 2025

A stock that deserves closer examination: INmune Bio Inc (INMB) - uspostnews.com

Apr 23, 2025

Apr 23, 2025

(INMB) Technical Data - news.stocktradersdaily.com

Apr 23, 2025

Apr 22, 2025

Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 22, 2025

Apr 16, 2025

Inmune Bio Secures Favorable Patentability Opinion for CORDStrom™ - TipRanks

Apr 16, 2025

Apr 16, 2025

INmune Bio secures key patent opinion for CORDStrom platform By Investing.com - Investing.com South Africa

Apr 16, 2025

Apr 16, 2025

INmune Bio Receives Favorable Opinion from USPTO on CORDStrom Patent Application - marketscreener.com

Apr 16, 2025